Search results
Jan 26, 2021 · Tue, Jan 26, 2021, 4:00 PM 4 min read. GAITHERSBURG, Md., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Arcellx, a privately held clinical-stage biopharmaceutical company developing adaptive and controllable ...
- Arcellx, Inc.
Dec 28, 2016 · 1. David Hilbert has spent the past 20+ years combining his disciplined approach to science with the business of effective drug development and corporate management. He is currently President and CEO at Arcellx, Inc., a company focused on the development of regulated immune cell therapies for treatment of human disease. From 2009-2014, David ...
People also ask
When did arcellx close?
Who is arcellx?
How many investors does arcellx have?
Did arcellx raise money?
The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
- 25 West Watkins Mill Road Gaithersburg Maryland 20878 United States
- 130
- (240) 327-0603
Founders David Hilbert; Operating Status Active; Last Funding Type Post-IPO Equity; Legal Name Arcellx, Inc. Stock Symbol NASDAQ:ACLX ; Company Type For Profit; Contact Email info@arcellx.com
- Gaithersburg, Maryland
- David Hilbert
Arcellx was recently featured as one of Five Companies That Are Changing the Landscape for Cell and Gene Therapy and is led by founder David Hilbert, PhD and a veteran team of top-caliber scientists and executives. Earlier this year Arcellx raised $27M in Series A funding from several high caliber investment firms that include NEA, Novo, Takeda ...
- CEO at Biobuzz/Workforce Genetics
Jan 26, 2021 · Arcellx’s founder and CEO, David Hilbert, Ph.D., will transition to the new role of Chief Technical Officer. “I’m thrilled to join Arcellx and honored to lead the company as it advances...
Apr 13, 2021 · Gaithersburg's Arcellx just raised a gargantuan $115 million in Series C financing. Here's what biopharmaceutical company plans to do with it. The latest injection follows an $85 million raise in ...
